Chronic Kidney Disease
108 Questions
1 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

Which scenario describes a drug-related risk for patients with kidney disease?

  • The drug is eliminated through the liver instead of the kidneys
  • The drug is contraindicated due to increased calcium reabsorption
  • The drug is metabolized faster due to kidney impairment
  • The drug becomes less effective as kidney function declines (correct)

    • What happens to P04 levels in patients with kidney disease?

  • P04 levels remain stable regardless of kidney function
  • P04 levels fluctuate based on calcium reabsorption
  • P04 levels decrease due to decreased absorption from the diet
  • P04 levels increase due to the kidneys' inability to eliminate excess P04 (correct)

    • What effect does reduced kidney function have on calcium reabsorption?

  • Reduced kidney function causes excessive calcium reabsorption
  • Reduced kidney function leads to decreased calcium reabsorption (correct)
  • Reduced kidney function leads to increased vitamin D activation
  • Reduced kidney function has no impact on calcium reabsorption

    • How does high P04 and low Ca levels affect the release of PTH in patients with healthy kidneys?

    <p>Both cause increased release of PTH</p> Signup and view all the answers

    What is the maximal action time for the serum potassium level to start trending down after insulin and glucose administration?

    <p>10–20 minutes</p> Signup and view all the answers

    What is the recommended dose of albuterol via nebulizer for shifting potassium into cells?

    <p>10–20 mg</p> Signup and view all the answers

    What are the most common side effects of beta-agonists?

    <p>Tachycardia and tremors</p> Signup and view all the answers

    What is the recommended bolus of insulin with glucose for hyperglycemic patients to avoid worsening of hyperkalemia?

    <p>10 units of insulin with 25–50 g of glucose</p> Signup and view all the answers

    What is the effect of beta-agonists and insulin together in lowering potassium level?

    <p>Additive and superior to using each of them alone</p> Signup and view all the answers

    What is the usual duration of the effect of insulin and glucose administration on serum potassium level?

    <p>2–6 hours</p> Signup and view all the answers

    What is the main reason for the ineffectiveness of inhaled beta-agonists in some patients?

    <p>Patients taking beta-blockers</p> Signup and view all the answers

    In which patients is the use of bicarbonate therapy controversial?

    <p>Patients without metabolic acidosis</p> Signup and view all the answers

    Which type of phosphate binder is rarely used due to the risk of aluminum accumulation?

    <p>Aluminum-based</p> Signup and view all the answers

    Which type of phosphate binder can lead to hypercalcemia, especially with concomitant use of vitamin D?

    <p>Calcium-based</p> Signup and view all the answers

    Which phosphate binder has no aluminum accumulation and less hypercalcemia but may cause other side effects?

    <p>Aluminum-free, calcium-free</p> Signup and view all the answers

    Phosphate binders should be administered separately from which type of medication?

    <p>Levothyroxine</p> Signup and view all the answers

    What is primarily used to treat elevations in parathyroid hormone (PTH) after controlling hyperphosphatemia?

    <p>Vitamin D</p> Signup and view all the answers

    Which medication mimics the actions of calcium on the parathyroid gland and reduces PTH?

    <p>Cinacalcet</p> Signup and view all the answers

    What is primarily responsible for anemia in chronic kidney disease (CKD)?

    <p>Lack of erythropoietin (EPO)</p> Signup and view all the answers

    What worsens bone disease and increases the risk of cardiovascular disease in CKD patients?

    <p>Vitamin D deficiency</p> Signup and view all the answers

    Which supplementation may be necessary, especially in early CKD stages?

    <p>Vitamin D</p> Signup and view all the answers

    What is the primary cause of anemia in CKD?

    <p>Decreased red blood cell (RBC) production</p> Signup and view all the answers

    Which medication is used to reduce PTH and can cause hypocalcemia in dialysis patients?

    <p>Cinacalcet</p> Signup and view all the answers

    Which mineral deficiency may worsen bone disease in CKD patients?

    <p>Phosphorus deficiency</p> Signup and view all the answers

    Which statement about anemia in chronic kidney disease is correct?

    <p>Anemia of CKD is also known as anemia of chronic disease</p> Signup and view all the answers

    What is a risk associated with ESAs like epoetin alfa and darbepoetin alfa?

    <p>Elevated blood pressure and thrombosis</p> Signup and view all the answers

    At what hemoglobin level should ESAs be discontinued?

    <p>If it exceeds 11 g/dL</p> Signup and view all the answers

    What is essential for ESAs to be effective in treating anemia of CKD?

    <p>Adequate iron</p> Signup and view all the answers

    How is hyperkalemia defined?

    <p>Potassium level &gt; 5.3 or &gt; 5.5 mEq/L</p> Signup and view all the answers

    What can increase the risk of hyperkalemia?

    <p>High dietary potassium intake or use of drugs like ACE inhibitors</p> Signup and view all the answers

    What are symptoms of hyperkalemia?

    <p>Muscle weakness, bradycardia, and fatal arrhythmias</p> Signup and view all the answers

    Which of the following drugs can raise potassium levels?

    <p>ACE inhibitors, ARBs, and potassium supplements</p> Signup and view all the answers

    What is used to cause potassium to shift into cells in the treatment of severe hyperkalemia?

    <p>Insulin and glucose</p> Signup and view all the answers

    What is the role of calcium therapy in severe hyperkalemia?

    <p>To prevent potential lethal arrhythmias</p> Signup and view all the answers

    What does insulin do in the treatment of severe hyperkalemia?

    <p>Causes potassium to shift into cells by increasing Na–K-ATPase activity</p> Signup and view all the answers

    When should calcium therapy be administered in patients taking digitalis?

    <p>Cautiously</p> Signup and view all the answers

    Patients with healthy kidneys do not experience bone demineralization and increased fractures due to increased release of PTH

    <p>True</p> Signup and view all the answers

    In CKD, the kidneys can activate vitamin D to increase dietary calcium absorption

    <p>False</p> Signup and view all the answers

    In CKD, drug accumulation may be unsafe due to increased risk of bleeding with some anticoagulants

    <p>True</p> Signup and view all the answers

    In CKD, the kidneys can effectively increase calcium reabsorption in response to high P04 and low Ca levels

    <p>False</p> Signup and view all the answers

    Insulin alone can be given to hyperglycemic patients to avoid worsening of hyperkalemia by hyperosmolar state

    <p>False</p> Signup and view all the answers

    The recommended dose of albuterol via nebulizer for shifting potassium into cells is 10–20 mg

    <p>True</p> Signup and view all the answers

    Sodium bicarbonate is recommended for patients without metabolic acidosis to reduce potassium levels

    <p>False</p> Signup and view all the answers

    The effect of beta-agonists and insulin together is not additive in lowering potassium level

    <p>False</p> Signup and view all the answers

    Bicarbonate therapy may cause hypernatremia, hypocalcemia, metabolic alkalosis, and hypervolemic state

    <p>True</p> Signup and view all the answers

    Inhaled beta-agonists are usually ineffective in patients taking beta-blockers

    <p>True</p> Signup and view all the answers

    The effect of beta-agonists and insulin together is generally ineffective in 30%–40% of patients for unknown reasons

    <p>False</p> Signup and view all the answers

    Insulin and glucose administration has a maximal action on serum potassium level within 30–40 min

    <p>False</p> Signup and view all the answers

    Phosphate binders are primarily used to increase the absorption of dietary phosphate in the intestine.

    <p>False</p> Signup and view all the answers

    Aluminum-based phosphate binders are rarely used due to the risk of aluminum accumulation, which can cause toxicity.

    <p>True</p> Signup and view all the answers

    Calcium-based phosphate binders can lead to hypercalcemia, especially with concomitant use of vitamin D.

    <p>True</p> Signup and view all the answers

    Aluminum-free and calcium-free phosphate binders have no aluminum accumulation and less hypercalcemia.

    <p>True</p> Signup and view all the answers

    Phosphate binders are known to have minimal drug interactions.

    <p>False</p> Signup and view all the answers

    After controlling hyperphosphatemia, elevations in PTH are primarily treated with iron supplements.

    <p>False</p> Signup and view all the answers

    Cinacalcet, a calcimimetic, is used in dialysis patients and can cause hypocalcemia.

    <p>True</p> Signup and view all the answers

    Anemia in CKD is primarily due to a lack of erythropoietin (EPO) produced by the kidneys.

    <p>True</p> Signup and view all the answers

    Vitamin D deficiency worsens bone disease and increases the risk of cardiovascular disease in CKD patients.

    <p>True</p> Signup and view all the answers

    Supplementation with oral ergocalciferol or cholecalciferol may not be necessary in early CKD stages.

    <p>False</p> Signup and view all the answers

    Phosphate binders are primarily used to block the absorption of dietary phosphate in the intestine.

    <p>True</p> Signup and view all the answers

    Phosphate binders should be administered separately from certain medications such as levothyroxine and antibiotics.

    <p>True</p> Signup and view all the answers

    Anemia of chronic kidney disease is also known as anemia of chronic disease

    <p>True</p> Signup and view all the answers

    ESAs like epoetin alfa and darbepoetin alfa can prevent the need for blood transfusions without any risks

    <p>False</p> Signup and view all the answers

    ESAs should only be used when hemoglobin is < 10 g/dL and discontinued if it exceeds 11 g/dL

    <p>True</p> Signup and view all the answers

    High dietary potassium intake or use of drugs like ACE inhibitors cannot increase the risk of hyperkalemia

    <p>False</p> Signup and view all the answers

    Insulin is effective in causing potassium to shift into cells by increasing Na–K-ATPase activity

    <p>True</p> Signup and view all the answers

    Calcium therapy is used to prevent potential lethal arrhythmias in severe hyperkalemia, and it should be administered cautiously in patients taking digitalis

    <p>True</p> Signup and view all the answers

    Adequate iron is not essential for ESAs to be effective in treating anemia of CKD

    <p>False</p> Signup and view all the answers

    Hyperkalemia is defined as potassium level > 5.3 or > 5.5 mEq/L; kidney failure is not the most common cause

    <p>False</p> Signup and view all the answers

    Treatment of severe hyperkalemia involves cardiac stabilization with calcium and shifting potassium into cells with insulin and glucose

    <p>True</p> Signup and view all the answers

    Anemia symptoms and an inflammatory state in CKD are not contributed by decreased EPO production

    <p>False</p> Signup and view all the answers

    Drugs that can raise potassium levels include ACE inhibitors, ARBs, and potassium supplements

    <p>True</p> Signup and view all the answers

    Symptoms of hyperkalemia include muscle weakness, bradycardia, and fatal arrhythmias; severe cases do not require urgent clinical intervention

    <p>False</p> Signup and view all the answers

    Which medication and dosage should be given to hyperglycemic patients to avoid worsening of hyperkalemia by hyperosmolar state?

    <p>Bolus of 10 units of insulin with 25–50 g of glucose should be given as an intravenous injection.</p> Signup and view all the answers

    What is the usual dose of albuterol via nebulizer for the treatment of hyperkalemia?

    <p>10–20 mg, at least four times higher than the usual dose used for patients with bronchospasm.</p> Signup and view all the answers

    What are the most common side effects of beta-agonists?

    <p>Tachycardia and tremors.</p> Signup and view all the answers

    In patients taking beta-blockers, inhaled beta-agonists are usually ineffective due to what reason?

    <p>Inhaled beta-agonists are usually ineffective in patients taking beta-blockers and generally ineffective in 30%–40% of patients for unknown reasons.</p> Signup and view all the answers

    What are the potential adverse effects of short-term bicarbonate therapy in patients without metabolic acidosis?

    <p>Hypernatremia, hypocalcaemia, metabolic alkalosis, and hypervolemic state.</p> Signup and view all the answers

    Why is the use of bicarbonate therapy controversial in patients without metabolic acidosis?

    <p>Short-term administration of bicarbonate does not reduce potassium level and may cause various adverse effects.</p> Signup and view all the answers

    What is the additive effect of beta-agonists and insulin in lowering potassium levels?

    <p>The effect of beta-agonists and insulin together is additive in lowering potassium level, superior to using each of them alone, and may prevent insulin-induced hypoglycemia.</p> Signup and view all the answers

    What is the duration of the maximal action of insulin and glucose administration on serum potassium level?

    <p>The effect lasts for 2–6 hours.</p> Signup and view all the answers

    What are the common scenarios related to medications and kidney disease?

    <p>The common scenarios related to medications and kidney disease include drug elimination through the kidneys, dose reduction and/or dosing interval extension, nephrotoxicity, decreased drug effectiveness as kidney function declines, contraindications at specific levels of kidney impairment, and complex interactions of Ca, P04, and vitamin D in CKD.</p> Signup and view all the answers

    What are the effects of high P04 and low Ca levels on PTH release in patients with healthy kidneys?

    <p>High P04 and low Ca levels cause increased release of PTH in patients with healthy kidneys.</p> Signup and view all the answers

    What happens to P04 levels in patients with kidney disease?

    <p>P04 levels increase in patients with kidney disease because the kidneys cannot eliminate excess P04 absorbed from the diet.</p> Signup and view all the answers

    What is the primary cause of anemia in chronic kidney disease?

    <p>Anemia in chronic kidney disease is primarily due to a lack of erythropoietin (EPO) produced by the kidneys.</p> Signup and view all the answers

    What is the term for declining kidney function leading to decreased EPO production, causing anemia symptoms and contributing to an inflammatory state in CKD?

    <p>Anemia of chronic kidney disease (CKD)</p> Signup and view all the answers

    What are the risks associated with ESAs like epoetin alfa and darbepoetin alfa?

    <p>Elevated blood pressure and thrombosis</p> Signup and view all the answers

    When should ESAs be used and discontinued based on hemoglobin levels?

    <p>Used when hemoglobin is &lt; 10 g/dL and discontinued if it exceeds 11 g/dL</p> Signup and view all the answers

    What is essential for ESAs to be effective in treating anemia of CKD?

    <p>Adequate iron</p> Signup and view all the answers

    What is the definition of hyperkalemia?

    <p>Potassium level &gt; 5.3 or &gt; 5.5 mEq/L</p> Signup and view all the answers

    What are the symptoms of hyperkalemia?

    <p>Muscle weakness, bradycardia, and fatal arrhythmias</p> Signup and view all the answers

    What are the drugs that can raise potassium levels?

    <p>ACE inhibitors, ARBs, and potassium supplements</p> Signup and view all the answers

    What is the treatment for severe hyperkalemia involving cardiac stabilization and shifting potassium into cells?

    <p>Cardiac stabilization with calcium and shifting potassium into cells with insulin and glucose</p> Signup and view all the answers

    How does insulin cause potassium to shift into cells?

    <p>By increasing Na–K-ATPase activity</p> Signup and view all the answers

    What is used to prevent potential lethal arrhythmias in severe hyperkalemia?

    <p>Calcium therapy</p> Signup and view all the answers

    What is the most common cause of hyperkalemia?

    <p>Kidney failure</p> Signup and view all the answers

    What is the term for anemia of CKD, also known as anemia of chronic disease?

    <p>Anemia of chronic kidney disease (CKD)</p> Signup and view all the answers

    What are the three types of phosphate binders?

    <p>aluminum-based, calcium-based, and aluminum-free, calcium-free drugs</p> Signup and view all the answers

    Why are aluminum-based phosphate binders rarely used?

    <p>due to the risk of aluminum accumulation, which can cause toxicity</p> Signup and view all the answers

    What is the primary treatment for hyperphosphatemia in chronic kidney disease?

    <p>restricting dietary phosphate and may progress to the use of phosphate binders</p> Signup and view all the answers

    What can calcium-based phosphate binders lead to, especially with concomitant use of vitamin D?

    <p>hypercalcemia</p> Signup and view all the answers

    What is the primary cause of anemia in chronic kidney disease?

    <p>lack of erythropoietin (EPO) produced by the kidneys</p> Signup and view all the answers

    What is the primary treatment for elevations in parathyroid hormone (PTH) after controlling hyperphosphatemia?

    <p>vitamin D</p> Signup and view all the answers

    What is the role of Cinacalcet in reducing PTH?

    <p>mimics the actions of calcium on the parathyroid gland and reduces PTH</p> Signup and view all the answers

    What may worsen bone disease and increase the risk of cardiovascular disease in CKD patients?

    <p>Vitamin D deficiency</p> Signup and view all the answers

    What supplements may be necessary, especially in early CKD stages?

    <p>oral ergocalciferol or cholecalciferol</p> Signup and view all the answers

    What mineral deficiency worsens bone disease in CKD patients?

    <p>Vitamin D deficiency</p> Signup and view all the answers

    What should phosphate binders be administered separately from?

    <p>certain medications such as levothyroxine and antibiotics</p> Signup and view all the answers

    What is the primary cause of anemia in CKD?

    <p>lack of erythropoietin (EPO) produced by the kidneys</p> Signup and view all the answers

    Study Notes

    Anemia and Hyperkalemia in Chronic Kidney Disease

    • Declining kidney function leads to decreased EPO production, causing anemia symptoms and contributing to an inflammatory state in CKD
    • Anemia of CKD is also known as anemia of chronic disease
    • ESAs like epoetin alfa and darbepoetin alfa can prevent the need for blood transfusions but have risks, including elevated blood pressure and thrombosis
    • ESAs should only be used when hemoglobin is < 10 g/dL and discontinued if it exceeds 11 g/dL
    • Adequate iron is essential for ESAs to be effective, and IV iron supplementation may be necessary in ESRD
    • Hyperkalemia is defined as potassium level > 5.3 or > 5.5 mEq/L; kidney failure is the most common cause
    • High dietary potassium intake or use of drugs like ACE inhibitors can increase the risk of hyperkalemia
    • Symptoms of hyperkalemia include muscle weakness, bradycardia, and fatal arrhythmias; severe cases require urgent clinical intervention
    • Drugs that can raise potassium levels include ACE inhibitors, ARBs, and potassium supplements
    • Treatment of severe hyperkalemia involves cardiac stabilization with calcium and shifting potassium into cells with insulin and glucose
    • Insulin is effective in causing potassium to shift into cells by increasing Na–K-ATPase activity
    • Calcium therapy is used to prevent potential lethal arrhythmias in severe hyperkalemia, and it should be administered cautiously in patients taking digitalis

    Anemia and Hyperkalemia in Chronic Kidney Disease

    • Declining kidney function leads to decreased EPO production, causing anemia symptoms and contributing to an inflammatory state in CKD
    • Anemia of CKD is also known as anemia of chronic disease
    • ESAs like epoetin alfa and darbepoetin alfa can prevent the need for blood transfusions but have risks, including elevated blood pressure and thrombosis
    • ESAs should only be used when hemoglobin is < 10 g/dL and discontinued if it exceeds 11 g/dL
    • Adequate iron is essential for ESAs to be effective, and IV iron supplementation may be necessary in ESRD
    • Hyperkalemia is defined as potassium level > 5.3 or > 5.5 mEq/L; kidney failure is the most common cause
    • High dietary potassium intake or use of drugs like ACE inhibitors can increase the risk of hyperkalemia
    • Symptoms of hyperkalemia include muscle weakness, bradycardia, and fatal arrhythmias; severe cases require urgent clinical intervention
    • Drugs that can raise potassium levels include ACE inhibitors, ARBs, and potassium supplements
    • Treatment of severe hyperkalemia involves cardiac stabilization with calcium and shifting potassium into cells with insulin and glucose
    • Insulin is effective in causing potassium to shift into cells by increasing Na–K-ATPase activity
    • Calcium therapy is used to prevent potential lethal arrhythmias in severe hyperkalemia, and it should be administered cautiously in patients taking digitalis

    Phosphate Binders and Their Types

    • In chronic kidney disease (CKD), hyperphosphatemia contributes to elevated parathyroid hormone (PTH) levels and must be treated to prevent bone disease and fractures.
    • Treatment for hyperphosphatemia initially involves restricting dietary phosphate and may progress to the use of phosphate binders, which block the absorption of dietary phosphate in the intestine.
    • There are three types of phosphate binders: aluminum-based, calcium-based, and aluminum-free, calcium-free drugs.
    • Aluminum-based phosphate binders, such as Aluminum hydroxide, are potent but rarely used due to the risk of aluminum accumulation, which can cause toxicity.
    • Calcium-based phosphate binders, like calcium acetate and calcium carbonate, are first-line but can lead to hypercalcemia, especially with concomitant use of vitamin D.
    • Aluminum-free and calcium-free phosphate binders, such as Sucroferric oxyhydroxide and Sevelamer, have no aluminum accumulation and less hypercalcemia but may cause other side effects.
    • Phosphate binders have many drug interactions and should be administered separately from certain medications such as levothyroxine and antibiotics.
    • After controlling hyperphosphatemia, elevations in PTH are primarily treated with vitamin D, which may be supplemented orally or through vitamin D analogs like Calcitriol and Paricalcitol.
    • Cinacalcet, a calcimimetic, mimics the actions of calcium on the parathyroid gland and reduces PTH; it is used in dialysis patients and can cause hypocalcemia.
    • Anemia in CKD is primarily due to a lack of erythropoietin (EPO) produced by the kidneys, resulting in decreased red blood cell (RBC) production and low hemoglobin levels.
    • Vitamin D deficiency worsens bone disease and increases the risk of cardiovascular disease in CKD patients.
    • Supplementation with oral ergocalciferol or cholecalciferol may be necessary, especially in early CKD stages.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Description

    Test your knowledge of anemia and hyperkalemia in chronic kidney disease with this quiz. Explore the causes, symptoms, and management of these conditions, including the use of erythropoiesis-stimulating agents and treatment for hyperkalemia.

    More Like This

    Use Quizgecko on...
    Browser
    Open
    Browser
    Browser